# Risk: __Testing strategy limitations__ (PBN__Risk_1507)

## Property: has_RiskSubject

* [general population](../Stakeholder/PBN__Stakeholder_9)
* [healthcare workers](../Stakeholder/PBN__Stakeholder_68)

## Property: has_RiskISO_Impact

* [Living and working environment](../RiskISO/PBN__RiskISO_Purpose_1)

## Property: has_RiskSource

* [iezadi_effectiveness_2021](../Article/PBN__Article_19)

## Property: has_RiskName

Delayed detection of cases, underestimation of the true number of infections, challenges in contact tracing

## Property: has_RiskHealth

* [physical](../RiskHealth/PBN__RiskHealth_0)

## Property: has_RiskGBN

* [Yes](../RiskGBN/PBN__RiskGBN_1)

## Property: has_RiskTechnology

* [rapid antigen tests](../Technology/PBN__Technology_782)
* [testing automation](../Technology/PBN__Technology_783)
* [mobile testing units](../Technology/PBN__Technology_784)

## Property: has_RiskOwner

* [government](../Stakeholder/PBN__Stakeholder_73)
* [healthcare providers](../Stakeholder/PBN__Stakeholder_121)

## Property: has_RiskType

* [technological](../RiskType/PBN__RiskType_5)

## Property: has_RiskDescription

Limitations in COVID-19 testing strategies and capacity

## Property: has_RiskISO_Purpose

* [Resilience](../RiskISO/PBN__RiskISO_Impact_2)

## Property: has_RiskMitigation

* [Expand testing capacity, prioritize testing for high-risk individuals and settings, implement targeted testing strategies](../RiskMitigation/PBN__RiskMitigation_2032)

